Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Immunology and bone.

Danks L, Takayanagi H.

J Biochem. 2013 Jul;154(1):29-39. doi: 10.1093/jb/mvt049. Epub 2013 Jun 7. Review.

PMID:
23750028
2.

Osteoimmunology: crosstalk between the immune and bone systems.

Nakashima T, Takayanagi H.

J Clin Immunol. 2009 Sep;29(5):555-67. doi: 10.1007/s10875-009-9316-6. Epub 2009 Jul 8. Review.

PMID:
19585227
3.

New insights into osteoclastogenic signaling mechanisms.

Nakashima T, Hayashi M, Takayanagi H.

Trends Endocrinol Metab. 2012 Nov;23(11):582-90. doi: 10.1016/j.tem.2012.05.005. Epub 2012 Jun 15. Review.

PMID:
22705116
4.

[RANKL signal and osteoimmunology].

Nakashima T, Takayanagi H.

Clin Calcium. 2011 Aug;21(8):1131-40. doi: CliCa110811311140. Review. Japanese.

PMID:
21814017
5.

[Osteoclast biology and osteoimmunology].

Nakashima T.

Nihon Rinsho Meneki Gakkai Kaishi. 2015;38(1):17-25. doi: 10.2177/jsci.38.17. Review. Japanese.

6.

New regulation mechanisms of osteoclast differentiation.

Nakashima T, Takayanagi H.

Ann N Y Acad Sci. 2011 Dec;1240:E13-8. doi: 10.1111/j.1749-6632.2011.06373.x. Review.

PMID:
22360322
7.

RANK/RANKL: regulators of immune responses and bone physiology.

Leibbrandt A, Penninger JM.

Ann N Y Acad Sci. 2008 Nov;1143:123-50. doi: 10.1196/annals.1443.016. Review.

PMID:
19076348
8.

[Osteoimmunology-overview].

Okamoto K, Takayanagi H.

Clin Calcium. 2012 Nov;22(11):1641-9. doi: CliCa121116411649. Review. Japanese.

PMID:
23103807
9.

DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.

Mori K, Le Goff B, Charrier C, Battaglia S, Heymann D, Rédini F.

Bone. 2007 Apr;40(4):981-90. Epub 2006 Dec 28.

10.

Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment.

Criscitiello C, Viale G, Gelao L, Esposito A, De Laurentiis M, De Placido S, Santangelo M, Goldhirsch A, Curigliano G.

Cancer Treat Rev. 2015 Feb;41(2):61-8. doi: 10.1016/j.ctrv.2014.12.001. Epub 2014 Dec 8. Review.

PMID:
25499997
11.

RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases.

Baud'huin M, Lamoureux F, Duplomb L, Rédini F, Heymann D.

Cell Mol Life Sci. 2007 Sep;64(18):2334-50. Review.

PMID:
17530461
12.

[Molecular determinants in osteoclast differentiation and osteoimmunology].

Takayanagi H.

Rinsho Ketsueki. 2009 Jun;50(6):447-52. Review. Japanese. No abstract available.

PMID:
19571503
14.

Osteoclasts and the immune system.

Nakashima T, Takayanagi H.

J Bone Miner Metab. 2009;27(5):519-29. doi: 10.1007/s00774-009-0089-z. Epub 2009 May 20. Review.

PMID:
19455385
15.

The dynamic interplay between osteoclasts and the immune system.

Nakashima T, Takayanagi H.

Arch Biochem Biophys. 2008 May 15;473(2):166-71. doi: 10.1016/j.abb.2008.04.004. Epub 2008 Apr 8. Review.

PMID:
18410741
16.

Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.

Kim SD, Kim HN, Lee JH, Jin WJ, Hwang SJ, Kim HH, Ha H, Lee ZH.

Biochem Pharmacol. 2013 Sep 15;86(6):782-90. doi: 10.1016/j.bcp.2013.07.015. Epub 2013 Aug 6.

PMID:
23928189
17.

Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system.

Tanaka S.

Am J Nephrol. 2007;27(5):466-78. Epub 2007 Jul 25. Review. Erratum in: Am J Nephrol. 2007;27(5):544.

PMID:
17652963
18.

Osteoimmunology in orthodontic tooth movement.

Jiang C, Li Z, Quan H, Xiao L, Zhao J, Jiang C, Wang Y, Liu J, Gou Y, An S, Huang Y, Yu W, Zhang Y, He W, Yi Y, Chen Y, Wang J.

Oral Dis. 2015 Sep;21(6):694-704. doi: 10.1111/odi.12273. Epub 2014 Aug 14. Review. Erratum in: Oral Dis. 2016 Jul;22(5):454-6.

PMID:
25040955
19.

Action of RANKL and OPG for osteoclastogenesis.

Kobayashi Y, Udagawa N, Takahashi N.

Crit Rev Eukaryot Gene Expr. 2009;19(1):61-72. Review.

PMID:
19191757
20.

Molecular pathways: osteoclast-dependent and osteoclast-independent roles of the RANKL/RANK/OPG pathway in tumorigenesis and metastasis.

Dougall WC.

Clin Cancer Res. 2012 Jan 15;18(2):326-35. doi: 10.1158/1078-0432.CCR-10-2507. Epub 2011 Oct 26.

Supplemental Content

Support Center